This company has been marked as potentially delisted and may not be actively trading. Enfusion (ENFN) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Enfusion (NYSE:ENFN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage36.44%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$1.35M Get ENFN Insider Trade Alerts Want to know when executives and insiders are buying or selling Enfusion stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ENFN Insider Buying and Selling by Quarter Enfusion Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/6/2025Oleg MovchanCEOSell11,452$11.39$130,438.28 3/5/2025Bradley HerringCFOSell4,645$11.38$52,860.10 3/5/2025Bradley HerringCFOSell4,645$11.38$52,860.10 3/5/2025Bronwen BastoneInsiderSell3,126$11.38$35,573.88 3/5/2025Matthew CampobassoGeneral CounselSell1,695$11.38$19,289.10 3/5/2025Neal PawarCOOSell14,560$11.38$165,692.80 3/5/2025Neal PawarCOOSell14,560$11.38$165,692.80 3/5/2025Valeria GutowskiCAOSell542$11.38$6,167.96 3/5/2025Valeria GutowskiCAOSell542$11.38$6,167.96 3/3/2025Bradley HerringCFOSell1,533$11.48$17,598.84 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/3/2025Bronwen BastoneInsiderSell2,064$11.48$23,694.72 3/3/2025Matthew CampobassoGeneral CounselSell1,081$11.48$12,409.88 3/3/2025Neal PawarCOOSell2,769$11.48$31,788.12 3/3/2025Oleg MovchanCEOSell2,790$11.48$32,029.20 3/3/2025Valeria GutowskiCAOSell219$11.48$2,514.12 1/13/2025Deirdre SomersDirectorSell1,637$10.53$17,237.61 1/7/2025Bradley HerringCFOSell4,134$10.13$41,877.42 1/7/2025Bronwen BastoneInsiderSell809$10.13$8,195.17 1/7/2025Matthew CampobassoGeneral CounselSell976$10.13$9,886.88 1/7/2025Oleg MovchanCEOSell2,771$10.13$28,070.23 1/7/2025Valeria GutowskiCAOSell796$10.13$8,063.48 12/20/2024Bradley HerringCFOSell24,443$10.61$259,340.23 12/2/2024Neal PawarCOOSell21,801$10.03$218,664.03 10/22/2024Matthew CampobassoGeneral CounselSell674$8.95$6,032.30 (Data available from 1/1/2013 forward) ENFN Insider Trading Activity - Frequently Asked Questions Who is on Enfusion's Insider Roster? The list of insiders at Enfusion includes Bradley Herring, Bronwen Bastone, Dan Groman, Deirdre Somers, Matthew Campobasso, Neal Pawar, Oleg Movchan, Stephen Malherbe, Tarek Hammoud, and Valeria Gutowski. Learn more on insiders at ENFN. What percentage of Enfusion stock is owned by insiders? 36.44% of Enfusion stock is owned by insiders. Learn more on ENFN's insider holdings. Which Enfusion insiders have been selling company stock? The following insiders have sold ENFN shares in the last 24 months: Bradley Herring ($442,978.23), Bronwen Bastone ($305,110.84), Dan Groman ($140,650.00), Deirdre Somers ($71,431.71), Matthew Campobasso ($66,406.23), Neal Pawar ($581,837.75), Oleg Movchan ($2,716,990.56), Stephen Malherbe ($9,860,000.00), and Valeria Gutowski ($33,427.09). How much insider selling is happening at Enfusion? Insiders have sold a total of 1,431,643 Enfusion shares in the last 24 months for a total of $14,218,832.41 sold. Enfusion Key ExecutivesMr. Oleg Movchan (Age 49)CEO & Director Compensation: $834.79k2 recent tradesMr. Bradley Herring (Age 53)Chief Financial Officer Compensation: $574.12k3 recent tradesMr. Neal Pawar (Age 52)Chief Operating Officer Compensation: $469.39k3 recent tradesMr. Stephen MalherbeManaging PartnerMs. Valeria Gutowski (Age 42)Chief Accounting Officer 3 recent tradesMr. Daniel Groman (Age 35)Chief Technology Officer Mr. Ignatius Tochukwu NjokuHead of Investor RelationsMr. Matthew R. Campobasso (Age 45)General Counsel & Corporate Secretary 2 recent tradesMs. Bronwen Bastone (Age 51)Chief People Officer Compensation: $566.25k2 recent tradesMr. Joseph DefeoGlobal Head of Managed Services Production More Insider Trading Tools from MarketBeat Related Companies Science Applications International Insider Transactions JFrog Insider Transactions SoundHound AI Insider Transactions Q2 Insider Transactions OneStream Insider Transactions Trump Media & Technology Group Insider Transactions CLEAR Secure Insider Transactions Zeta Global Insider Transactions BOX Insider Transactions Workiva Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Costco Faces Downgrades, Death Cross, Insider SellingReynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say Buy This page (NYSE:ENFN) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enfusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enfusion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
